NONHODGKINS LYMPHOMA OF THE MALE URETHRA

被引：7

作者：

RAJAN, N ^{[1
]}

ALLMAN, D ^{[1
]}

SCAGLIA, B ^{[1
]}

BANNO, J ^{[1
]}

STUART, R ^{[1
]}

COLOMBO, G ^{[1
]}

HERNANDEZGRAULAU, J ^{[1
]}

机构：

[1] UNIV ILLINOIS,DEPT SURG,PEORIA,IL 61656

来源：

JOURNAL OF UROLOGY | 1995年 / 153卷 / 06期

关键词：

LYMPHOMA; NON-HODGKINS; PENIS; URETHRA;

D O I：

10.1016/S0022-5347(01)67353-1

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Ten cases of malignant lymphoma of the female urethra have been reported. To our knowledge we report the first such case in a man who presented in acute urinary retention with a mass protruding from the urethral meatus. Multiple subcutaneous nodules developed over the anterior abdominal wall and a 3 x 3 cm. mass developed above the umbilicus. Wedge resection of this mass was consistent with large cell lymphoma. Treatment consisted of 2 courses of arabinoside C, doxorubicin and prednisone. Followup 6 months later showed no urethral or other recurrence. Local excision, radical excision, radiotherapy (external beam and intracavitary) and chemotherapy have been used with success in other cases.

引用

页码：1916 / 1917

页数：2

共 8 条

[1] Weimar, Culp, Loening, Narayana, Urogenital involvement by malignant lymphomas, J. Urol., 125, (1982)
[2] Vapnek, Turzan, Primary malignant lymphoma of the female urethra: report of a case and review of the literature, J. Urol., 147, (1992)
[3] Cancer Facts and Figures--1984, (1983)
[4] Bierman, Vose, Armitage, Clinical manifestations, staging and treatment of Non-Hodgkin's lymphoma, Hematology--Basic Principles and Practice, (1991)
[5] Whitmore, Sharkin, Rosenthal, Urological presentations of nonHodgkin's lymphomas, J. Urol., 128, (1982)
[6] Freeman, Berg, Cutler, Occurrence and prognosis of extranodal lymphomas, Cancer, 29, (1972)
[7] Magrath, The Non-Hodgkin's Lymphomas, (1990)
[8] The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas Summary and description of a working formulation for clinical usage, Cancer, 49, (1982)

← 1 →